MX2024005658A - Inhibidores de proteina tirosina fosfatasa y metodos de uso de estos. - Google Patents

Inhibidores de proteina tirosina fosfatasa y metodos de uso de estos.

Info

Publication number
MX2024005658A
MX2024005658A MX2024005658A MX2024005658A MX2024005658A MX 2024005658 A MX2024005658 A MX 2024005658A MX 2024005658 A MX2024005658 A MX 2024005658A MX 2024005658 A MX2024005658 A MX 2024005658A MX 2024005658 A MX2024005658 A MX 2024005658A
Authority
MX
Mexico
Prior art keywords
methods
protein tyrosine
tyrosine phosphatase
phosphatase inhibitors
sup
Prior art date
Application number
MX2024005658A
Other languages
English (en)
Spanish (es)
Inventor
Andrew Bogdan
Jennifer M Frost
Philip R Kym
Zhaoming Xiong
Elliot P Farney
Naomi Anne Barton
Claire Anne Marie Cariou-Mumford
Christopher Patrick Mcmahon
Giuseppe Nano
Original Assignee
Calico Life Sciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calico Life Sciences Llc filed Critical Calico Life Sciences Llc
Publication of MX2024005658A publication Critical patent/MX2024005658A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX2024005658A 2021-11-11 2022-11-10 Inhibidores de proteina tirosina fosfatasa y metodos de uso de estos. MX2024005658A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163278339P 2021-11-11 2021-11-11
PCT/US2022/049584 WO2023086498A1 (en) 2021-11-11 2022-11-10 Protein tyrosine phosphatase inhibitors and methods of use thereof

Publications (1)

Publication Number Publication Date
MX2024005658A true MX2024005658A (es) 2024-08-06

Family

ID=84689141

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024005658A MX2024005658A (es) 2021-11-11 2022-11-10 Inhibidores de proteina tirosina fosfatasa y metodos de uso de estos.

Country Status (8)

Country Link
US (1) US20250019374A1 (cg-RX-API-DMAC7.html)
EP (1) EP4430038A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024543452A (cg-RX-API-DMAC7.html)
CN (1) CN118525016A (cg-RX-API-DMAC7.html)
AU (1) AU2022387106A1 (cg-RX-API-DMAC7.html)
CA (1) CA3236854A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024005658A (cg-RX-API-DMAC7.html)
WO (1) WO2023086498A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024243441A1 (en) 2023-05-24 2024-11-28 Kumquat Biosciences Inc. Heterocyclic compounds and uses thereof
CN121487923A (zh) * 2023-07-28 2026-02-06 杭州中美华东制药有限公司 具有ptpn2抑制作用的化合物及其用途
WO2025242216A1 (zh) * 2024-05-24 2025-11-27 杭州百新生物医药科技有限公司 吲哚啉类化合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA94724C2 (en) * 2005-12-08 2011-06-10 Новартис Аг Thiadiazolidinone derivatives as antidiabetic agents
UA94921C2 (en) * 2005-12-08 2011-06-25 Новартис Аг 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors
TWI888352B (zh) * 2018-06-21 2025-07-01 美商嘉來克生命科學有限責任公司 蛋白質酪胺酸磷酸酯酶抑制劑及其使用方法
KR102983496B1 (ko) * 2019-03-14 2026-06-29 칼리코 라이프 사이언시스 엘엘씨 단백질 티로신 포스파타제 억제제 및 이의 사용 방법
MX2022007441A (es) * 2019-12-18 2022-09-02 Calico Life Sciences Llc Inhibidores de proteína tirosina fosfatasa y sus métodos de uso.

Also Published As

Publication number Publication date
CN118525016A (zh) 2024-08-20
AU2022387106A1 (en) 2024-05-23
US20250019374A1 (en) 2025-01-16
EP4430038A1 (en) 2024-09-18
WO2023086498A1 (en) 2023-05-19
JP2024543452A (ja) 2024-11-21
CA3236854A1 (en) 2023-05-19

Similar Documents

Publication Publication Date Title
BR112021023136A2 (pt) Compostos heterocíclicos, métodos de preparação e usos dos mesmos
MX2024001824A (es) Compuestos heterociclicos y metodos de uso.
MX2021013662A (es) Inhibidores de la autofagia de heteroarilaminopirimidina amida y metodos de uso de estos.
MX2025004109A (es) Inhibidores heterocíclicos de las proteínas mutantes kras g12c y utilizaciones de los mismos
MX2021007833A (es) Inhibidores aza-heterobiciclicos de mat2a y metodos de uso en el tratamiento de cancer.
EA202191801A1 (ru) Гетероциклические ингибиторы mat2a и способы применения для лечения рака
MX2025015186A (es) Inhibidores de pi3k y uso de estos
JOP20200315A1 (ar) مركبات بورينون واستخدامها في معالجة السرطان
CR20220234A (es) Degradadores de moléculas pequeñas de helios y procedimientos de uso
EA202092320A1 (ru) Гетеробициклические ингибиторы mat2a и способы использования для лечения злокачественной опухоли
AU2020281332A8 (en) Dna-dependent protein kinase inhibitor
MX2023004802A (es) Compuestos espiro heterocíclicos y métodos de uso.
EA200300248A1 (ru) Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции
EA200801041A1 (ru) Ингибиторы мек и способы их применения
EA200400006A1 (ru) Бензоилсульфонамиды и сульфонилбензамидины для применения в качестве противоопухолевых агентов
MX2022001151A (es) Inhibidores deuterados de la via mk2 y metodos de uso de los mismos.
MX379459B (es) Inhibidores de bromodominios.
EA200500299A1 (ru) Пиразольные композиции, используемые в качестве ингибиторов gsk-3
DE60333387D1 (de) Triazolopyridazine als proteinkinase-inhibitoren
ZA202304734B (en) Alpha protein kinase 1 inhibitors and methods of use
CR20230382A (es) Derivados de tetrahidroazepina bicíclicos para el tratamiento del cáncer
ATE493418T1 (de) Dihydrofuropyrimidine als akt- proteinkinaseinhibitoren
PH12021551304A1 (en) Tyrosine kinase inhibitors, compositions and methods there of
MX2022011194A (es) Bloqueadores de canales ionicos cargados y metodos de uso.
MX2023011408A (es) Compuestos de oxoisoindolina sustituidos con piridinilo para el tratamiento de cancer.